The Experiment of Noiiglutide Injection in Type 2 Diabetes Patients
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-09-30
Target enrollment:
Participant gender:
Summary
This study aims to confirm that SHR20004 is more effective than placebo in controlling blood glucose in patients with type 2 diabetes. Evaluate the efficacy, safety, and pharmacokinetics of SHR20004 after 24 weeks of treatment.